Tue, Mar 3, 2015, 7:51 PM EST - U.S. Markets closed


% | $
Quotes you view appear here for quick access.

Sarepta Therapeutics, Inc. Message Board

  • lawman_greg lawman_greg Feb 4, 2013 12:12 AM Flag

    Fox 5 News Leaks SRPT Date w/ FDA for Early Approval. LINK

    Posted: Jan 31, 2013 5:22 PM EST Updated: Feb 01, 2013 9:36 AM EST
    By ADRIENNE SUPINO, Fox 5 News Reporter
    In July 2012, Pietro Scarso, 3, was diagnosed with Duchenne muscular dystrophy. Most children with this aggressive form of MD are in a wheelchair by age 10 and do not live beyond their teens.
    There is no cure for DMD, but Pietro's parents, Dayna and Manni, are determined to extend their son's life.
    Then they learned about an experimental new drug called Eteplirsen, which is in clinical trials. Manni Scarso said researchers initially were just trying to slow the progression of the disease but after 62 weeks they saw reversal.
    The drug is not yet approved by the FDA. The drug maker is scheduled to go before the FDA in mid-February.
    The Scarsos are hoping for an accelerated approval so they can start treating Pietro immediately. They hope this drug or any drug will be fast tracked to help save their little boy.

    SortNewest  |  Oldest  |  Most Replied Expand all replies
13.36-0.130(-0.96%)Mar 3 4:00 PMEST

Trending Tickers

Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.